ClearPoint Neuro (CLPT) Free Cash Flow Growth (5y) (2016 - 2026)
ClearPoint Neuro (CLPT) Free Cash Flow Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | ClearPoint Neuro | 464.87 Mn | 435.47 Mn | 6.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -14.39% |
| Mar 31, 2026 | -31.73% |
| Dec 31, 2025 | -38.30% |
| Sep 30, 2025 | -19.27% |
| Jun 30, 2025 | -8.93% |
| Mar 31, 2025 | -22.21% |
| Dec 31, 2024 | -26.44% |
| Sep 30, 2024 | -4.66% |
| Jun 30, 2024 | -26.92% |
| Mar 31, 2024 | -44.50% |
| Dec 31, 2023 | -15.33% |
| Sep 30, 2023 | -15.54% |
| Jun 30, 2023 | -36.40% |
| Mar 31, 2023 | -24.04% |
| Mar 31, 2021 | -5.18% |
| Dec 31, 2020 | -16.55% |
| Sep 30, 2020 | 3.90% |
| Jun 30, 2020 | 10.16% |
| Mar 31, 2020 | 3.64% |
| Dec 31, 2019 | -15.30% |